期刊文献+

细胞因子表达质粒对恶性疟原虫顶端膜抗原1DNA免疫的调节作用 被引量:3

Modulation of Immune Response to Plasmodium falciparum Apical Membrane Antigen 1 DNA Vaccine by Cytokine Plasmids
下载PDF
导出
摘要 目的 探讨细胞因子表达质粒对小鼠DNA免疫的促进和调节作用。 方法 构建编码恶性疟原虫顶端膜抗原 1(AMA1)完整胞外域的DNA免疫质粒VR10 2 0 /E ,构建编码小鼠细胞因子 (GM CSF)、白细胞介素 (IL)如IL 4和IL 12的真核表达质粒pcDNA3 /GM CSF、pcDNA3 .1( ) /IL 4和pIL 12以及双顺反子质粒pGM CSF/pTPA E ,分组免疫小鼠 ,ELISA检测血清中特异性IgG及其亚类的水平 ,取小鼠脾细胞进行体外增殖。 结果  3种细胞因子质粒均有效增强了小鼠针对VR10 2 0 /E的免疫应答 ,抗体水平增加 7至 10倍 ,其中pcDNA3 /GM CSF质粒和pIL 12质粒分别显著促进了小鼠的IgG1和IgG2a应答 ,小鼠脾细胞的体外增殖水平亦有明显提高。 结论 利用编码GM CSF、IL 4和IL 12的表达质粒作为佐剂可有效增强小鼠针对AMA1DNA的免疫应答 ,并对免疫应答的类型产生调节作用。 Objective To explore the effect of cytokine encoding plasmids on DNA immunization in mice. Methods Prototype DNA vaccine VR1020/E which contain Plasmodium falciparum apical membrane antigen 1 (AMA1) ectodomain was constructed, and eukaryotic expression vectors pcDNA3/GM-CSF, pcDNA3.1(-)/IL-4, pIL-12 and pGM-CSF/pTPA-E were also built. BALB/c mice were immunized with VR1020/E alone or with VR1020/E plus different cytokine plasmids. Serum IgG and its subtype were determined by ELISA and in vitro splenocyte proliferation assay was done. Results GM-CSF, IL-4 and IL-12 encoding plasmids all promoted mice immune response to VR1020/E, the antibody level increased 7 to 10 times and splenocyte proliferation was enhanced too. Plasmid pcDNA3/GM-CSF induced much more IgG1 whereas plasmid pIL-12 induced much more IgG2a. Conclusion Cytokine encoding plasmids might be used as adjuvant in AMA1 DNA immunization.
出处 《中国寄生虫学与寄生虫病杂志》 CAS CSCD 北大核心 2004年第3期136-138,共3页 Chinese Journal of Parasitology and Parasitic Diseases
基金 军队医药卫生基金 (0 1L0 59) 联合国发展计划署 /世界银行/世界卫生组织热带病研究与培训特别规划 (TDR)项目(A30 1 2 5)~~
关键词 细胞因子表达 质粒 恶性疟原虫 顶端膜抗原1 DNA免疫 调节作用 佐剂 Plasmodium falciparum Apical membrane antigen 1 DNA vaccine Cytokines Adjuvant, Immunologic
  • 相关文献

参考文献8

  • 1Gurunathan S, Klinman DM, Seder RA. DNA vaccines: Immunology, application, and optimization [ J]. Ann Rev Immunol, 2000,18:927-974.
  • 2Doolan DL, Hoffman SL. DNA-based vaccines against malaria: status and promise of the multi-stage malaria DNA vaccine operation[ J]. Int J Parasitol, 2001,31:753-762.
  • 3Anders RF, Crewther PE, Edwards S, et al. Immunization with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi[J]. Vaccine, 1998,16:240-247.
  • 4Narum DL, Ogun SA, Thomas AW, et al. Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection[ J]. Infect
  • 5Stowers AW, Kennedy MC, Keegan BP, et al. Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria[ J]. Infect Immun, 2002,70:6961-6967.
  • 6Klinman DM, Yi AK, Beaccage SL, et al. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma[J]. Proc Natl Acad Sci USA, 1996,93:2879-2883.
  • 7Jakob T, Walker PS, Krieg AM, et al. Activation of cutaneous debdritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA[ J]. J Immunol, 1998,161:3042-3049.
  • 8Wipasa J, Elliott S, Xu H, et al. Immunity to asexual blood stage malaria and vaccine approaches[ J]. Immunol Cell Biol, 2002,80:401-414.

同被引文献40

  • 1李淑梅,李珣,薛采芳,缪军,雷俊川,刘忠湘,王宪锋.恶性疟原虫裂殖子表面蛋白1 DNA与改良痘苗病毒组合疫苗诱导小鼠抗体应答[J].中国寄生虫学与寄生虫病杂志,2005,23(2):93-96. 被引量:3
  • 2李珣,薛采芳,缪军,李淑梅,刘忠湘,雷俊川,王宪锋.恶性疟原虫AMA1不同类型疫苗组合免疫接种研究[J].中华微生物学和免疫学杂志,2005,25(11):949-952. 被引量:3
  • 3John CC, O'Donnell RA, Sumba PO, et al. Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-1 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa[J]. J Immunol, 2004,173: 666-672.
  • 4de Koning-Ward TF, O'Donnell RA, Drew DR, et al. A new rodent model to assess blood stage immunity to the Plasmodium falciparum antigen merozoite surface protein 119 reveals a protective role for invasion inhibitory antibodies[J]. J Exp Med, 2003,198: 869-875.
  • 5Good MF, Kaslow DC, and Miller LH. Pathways and strategies for developing a malaria blood-stage vaccine [J].Annu Rev Immunol,1998, 16: 57-87.
  • 6Hirunpetcharat C, Tian JH, Kaslow DC,et al. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1(MSP1 [19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells [J]. J Immunol, 1997,159:3400-3411.
  • 7O'Donnell RA, de Koning-Ward TF, Burt RA, et al. Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria[J]. J Exp Med,2001,193: 1403-1412.
  • 8Ramshaw IA, Alistair JR. The prime-boost strategy: exciting prospects for improved vaccination[J]. Trends Immunol, 2000, 21: 163-165.
  • 9Pan WQ, Ravot E, Tolle R, et al. Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4 917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells [J]. Nucl Acid Res,1999,27:1094-1103.
  • 10Kawabata Y, Udono H, Honma K, et al. Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii[J]. Infect Immun, 2002,70: 6075-6082.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部